Occasionally, treatments come along that are of greater interest to patients than to doctors.Drops for treating presbyopia ...
The new vaccine is "personalized," meaning it is designed to train the patient's immune system to recognize and eliminate any remaining cells of that person's cancer.
D Molecular (FDMT) presented 52-week wet age-related macular degeneration Phase IIb results at this weekend’s Angiogenesis, Exudation, and ...
Clinical Trials Arena on MSN15h
Regeneron’s macular oedema therapy shows promise in Phase III trialIn the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.
News Medical on MSN17h
Research highlights gender and age differences in eye gene therapy responsesOlder women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found.
Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research ...
Loss to follow-up higher among men who are Black or Hispanic, or those who must travel farther to care facilities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback